Taniguchi Y, Shimokawa T, Takiguchi Y, Misumi T, et al. A randomized comparison of nivolumab versus nivolumab + docetaxel for previously treated advanced or recurrent ICI-naive non-small-cell lung cancer: TORG1630. Clin Cancer Res 2022 Aug 18. pii: 708059. doi: 10.1158/1078-0432.CCR-22-1687.
PMID: 35980349